Hi Wobmbie, this will make it clearer, it is a somewhat comparison for companies with early-on revenue creation
the grey faded numbers entered are estimates for the future, remember CEO said there is an uptick in sales in Webinar, and also they said break-even in 6 quarters or so, it means sales should point upwards by now.
the end columns are what MC and SP should be compared to what Telix had at that time in percentage comparisons calculated for Oncosil
true, the comparison is somewhat vague, ie larger product pipeline for Telix, but early revenue creation is something to go by and to compare
Ann: Letter to Short Dated Option Holders, page-14
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
-0.001(7.69%) |
Mkt cap ! $45.40M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.3¢ | 1.2¢ | $137.7K | 11.46M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1719369 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 3242606 | 5 |
View Market Depth
| Last trade - 15.10pm 18/10/2024 (20 minute delay) ? |
| OSL (ASX) Chart |